These observations suggest that carbonic anhydrases—likely via their ability to elevate tumor pHo (Figs. 6 and 8A)—provide an immune-stimulatory input that improves survival of patients with HER2-enriched breast cancer characterized by a weak immune response. The gene discussed is ERBB2; the disease is breast carcinoma.